HC Wainwright & Co. Maintains Buy on Regenxbio, Lowers Price Target to $26
Regenxbio Inc RGNX
$6.74
▼ -4.67%
($-0.33)
Open
$7.10
Prev Close
$7.07
Day Range
$6.58 – $7.13
52W Range
$5.46 – $16.19
Market Cap
$365.50M
Beta
1.03
EPS (TTM)
$-5.59
📋 Company Profile
| Industry | Biotechnology |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 2015-09-17 |
| Shares Out. | 51,700,000 |
| Website | regenxbio.com/ ↗ |
| Phone | 12405528181 |
Regenxbio Inc is a publicly traded company under the ticker symbol RGNX on the NASDAQ NMS - GLOBAL MARKET, operating in the Biotechnology industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
19 analysts (2026-06-01)